GE HealthCare and Masimo today announced a joint agreement to integrate patient monitoring technologies. The agreement aims to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare’s Portrait Mobile wireless, wearable patient monitoring solution. Portrait Mobile, built as an internet of medical things (IoMT) platform, uses cloud-native technology. It provides an end-to-end experience […]
Masimo
ITC rules in favor of Masimo in Apple Watch patent spat, stock rises
Masimo announced that the U.S. International Trade Commission (ITC) ruled in its favor in an ongoing patent battle with tech giant Apple. Shares of MASI ticked up more than 5% at $85.26 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. […]
Masimo’s LiDCO module wins CE mark for hemodynamic monitoring
Masimo today announced it received CE mark approval for its LiDCO board-in-cable (BIC) module in hemodynamic monitoring. The Irvine, California-based company designed LiDCO BIC to connect to multi-patient monitoring platforms, such as the Masimo Root Patient Monitoring and Connectivity Hub. It allows clinicians to easily add LiDCO hemodynamic monitoring with the company’s versatile PulseCO algorithm […]
Masimo initiates full U.S. launch of Stork smart home baby monitor
Masimo announced today that it initiated the full U.S. market release for its Stork home baby monitoring system. Stork offers a continuous and accurate view of a baby’s health data. It leverages Masimo’s noninvasive neonate monitoring technologies. The Irvine, California-based company kicked off its initial launch for the system in May of this year. “We […]
Masimo ‘disappointed’ in Q2 results, confirms slashed guidance
Masimo shares fell this morning after the company shared second-quarter results that included reduced 2023 guidance. Shares of MASI were down more than 2% at $117.11 apiece. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The guidance cut comes as no surprise after the […]
Masimo SedLine could improve brain monitoring during endoscopy, study says
Masimo today announced positive study findings from an evaluation of its SedLine brain function monitoring. Dr. Lichy Han and colleagues at Stanford University evaluated SedLine, publishing their findings in Frontiers in Neuroscience. They looked at SedLine’s ability to assess the sedation levels of patients undergoing drug-induced sleep endoscopy (DISE) with dexmedetomidine. Irvine, California-based Masimo said […]
Masimo expects to cut 2023 healthcare sales guidance by $150M, aims to reduce costs
Masimo announced preliminary second-quarter results that include a potentially significant reduction in sales guidance. Full-year guidance for Masimo’s healthcare business, previously set at $1.45 billion at the low end, is expected to be slashed to $1.3 billion. The company also said yesterday that it is still evaluating the upper end of its guidance, which could […]
Masimo loses board seats to activist investor Politan
Masimo shareholders voted to oust two members of the device developer’s board after a heated battle by activist investor Politan Capital Management. Masimo has yet to release official results, but acknowledged defeat today in a statement to MassDevice. “We are disappointed to have lost the valuable contributions of two very qualified and capable board […]
ISS backs Politan’s nominees in Masimo board battle; Device developer says CEO is the target
Politan Capital Management’s fight for two Masimo board seats won a key endorsement from proxy advisory firm Institutional Shareholder Services (ISS), the activist investor said today. ISS is recommending Masimo shareholders vote for Politan’s two board nominees: Politan Managing Partner and Chief Investment Officer Quentin Koffey and former Johnson & Johnson MedTech executive Michelle Brennan. […]
Masimo wins FDA clearance for wearable vital sign monitor
Masimo (Nasdaq:MASI) announced today that the FDA cleared its Radius VSM patient-worn, continuous, multi-parameter vital signs monitor. Radius VSM enables physicians to monitor a range of physiological measurements. That includes Masimo SET pulse oximetry, noninvasive blood pressure, temperature, respiration rate and ECG. Masimo said its monitor combines the reliability and accuracy of larger bedside monitors […]
New FDA clearance will boost Philips and Masimo partnership
Philips and Masimo today announced an FDA clearance that allows the incorporation of Masimo’s advanced monitoring tech into Philips’ existing high-acuity patient monitors. The FDA clearance allows the companies to use SedLine brain function monitoring, Regional Oximetry and CO2 measurements in Philips’ patient monitors, IntelliVue MX750 and MX850. This is the latest extension of Masimo […]